A lab-developed test is a test designed, made and used within a single laboratory, rather than a kit sold to many labs. Many specialty panels, including the GI-MAP stool test, fall into this group. The lab must meet federal quality standards for running tests, but the test itself usually has not been through FDA review of what its results mean for your health.
That does not make these tests bad. It means you should ask two separate questions: does the lab measure the marker reliably, and does the marker actually tell you something useful? Federal lab rules mainly answer the first.
Key takeaways
- Lab-developed tests are created and run inside one lab, and they are common in specialty testing.
- CLIA certification covers how well a lab performs testing, not whether a marker predicts or diagnoses disease.
- The FDA tried to regulate these tests as devices in 2024, but that rule was struck down and reversed in 2025.
- Accuracy claims on a report or website are worth reading closely: "validated" can mean measured precisely, not proven useful.
What a lab-developed test is
The FDA defines a laboratory developed test as one manufactured by and used within a single laboratory.1 You may also hear them called in-house or "home brew" tests. A hospital lab's custom genetic test and a specialty company's stool or antibody panel can both be lab-developed tests.
The alternative is a commercial test kit that a manufacturer sells to many labs. Those kits generally need FDA clearance or approval before they are sold, which includes a review of the evidence behind the test's intended use.
CLIA: the rules for the lab
In the US, any lab that tests human samples for health purposes is regulated under the Clinical Laboratory Improvement Amendments, known as CLIA. The program sets quality standards so results are accurate, reliable and timely, and requirements get stricter as tests get more complex.2 Lab-developed tests are treated as high complexity, so labs running them must meet the strictest tier.
Before a lab reports results from its own test, CLIA requires it to establish analytical performance: how accurate and precise the test is, and how sensitive and specific. The CMS program does not address the clinical validity of any test, meaning how well the result identifies or predicts a health condition.1
CAP accreditation
The College of American Pathologists (CAP) runs a voluntary accreditation program with detailed checklists and peer inspections. CMS has given the CAP program deeming authority, which allows a CAP inspection in place of a CMS inspection.3 CAP accreditation is a good sign about how a lab operates. Like CLIA, it focuses on lab quality rather than proving that every marker on a panel has clinical meaning.
Where FDA oversight stands in 2026
For decades the FDA said it had authority over lab-developed tests but generally chose not to enforce device rules on them. In May 2024 it issued a final rule to bring these tests clearly under device regulation. A federal court vacated that rule on March 31, 2025, and on September 19, 2025, the FDA issued a rule restoring the earlier regulation text.4
The practical result for patients in 2026: lab-developed specialty tests continue to be offered under CLIA, generally without FDA premarket review of their clinical claims.
| Question | Lab-developed test | FDA-cleared or approved kit |
|---|---|---|
| Who makes it? | One lab, for use in that lab | A manufacturer, sold to many labs |
| Lab quality rules (CLIA) | Yes, high complexity | Yes, based on the test's complexity |
| FDA review of clinical claims | Generally not | Yes, before marketing |
| Who checks what a result means? | The lab, published studies and your clinician | FDA review, plus studies and your clinician |
What this means for accuracy claims
Specialty labs often describe their quality in strong terms. The lab behind the GI-MAP states that it is CLIA certified and that it uses quantitative PCR, a DNA-based method.5 Vibrant Wellness, which makes the Wheat Zoomer, says its testing runs in a CLIA-certified and CAP-accredited lab.6 Those are meaningful statements about lab quality.
They do not settle the second question. A PCR test can reliably detect a microbe's DNA in stool, and that still does not prove the microbe is causing your symptoms. An antibody panel can measure reproducibly, and some of its markers can still be research-stage. When you read "validated," ask: validated for what?
A few practical checks help:
- Is there published, peer-reviewed research on this test or marker in people like you?
- Does the report explain how reference ranges were set, and in what population?
- Would a guideline-based test answer the same question? If so, which comes first?
- Will a clinician interpret the results alongside your history and standard labs?
For a broader checklist, see questions to ask before a functional medicine test.
Your next step
To see how a clinician chooses tests, reviews results with you and turns them into a plan, read how specialty testing works at YoungerMeMD. Each test's strengths and limits are covered in the Specialty Testing Guide, including the GI-MAP guide.
Frequently asked questions
Does "not FDA approved" mean a test is inaccurate?
No. Many lab-developed tests are run carefully and give reliable measurements. It means the FDA has generally not reviewed evidence that the result predicts or diagnoses a condition, so that evidence is something you and your clinician weigh.
How can I check a lab's CLIA status?
Labs usually state their CLIA certification on their website or report. You can also ask the clinician ordering the test which lab runs it and how it is accredited.
Are lab-developed tests common in hospitals too?
Yes. Many hospital and academic labs develop their own tests, especially for genetic and rare conditions. The category describes how a test is made and regulated, not whether it is mainstream or alternative.
Could FDA rules change again?
They could. Oversight of lab-developed tests has been debated for years, and Congress or the FDA could act in the future. As of 2026, the 2024 rule is no longer in effect.
Related reading
This article is for general education and is not medical advice. Decisions about testing and treatment should be made with your clinician. If you have severe symptoms, call 911. For a suspected poisoning, call Poison Control at 1-800-222-1222.
